Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) Net Income towards Common Stockholders (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of Net Income towards Common Stockholders data on record, last reported at -$42.9 million in Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 28.25% year-over-year to -$42.9 million; the TTM value through Dec 2025 reached -$116.4 million, up 24.97%, while the annual FY2025 figure was -$116.4 million, 24.97% up from the prior year.
  • Net Income towards Common Stockholders reached -$42.9 million in Q4 2025 per TCNNF's latest filing, down from -$26.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $40.9 million in Q2 2021 and bottomed at -$403.8 million in Q2 2023.
  • Average Net Income towards Common Stockholders over 5 years is -$51.3 million, with a median of -$32.4 million recorded in 2022.
  • The widest YoY moves for Net Income towards Common Stockholders: up 115.86% in 2021, down 2453.36% in 2021.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$71.5 million in 2021, then fell by 7.69% to -$77.0 million in 2022, then surged by 56.61% to -$33.4 million in 2023, then crashed by 78.83% to -$59.8 million in 2024, then grew by 28.25% to -$42.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$42.9 million in Q4 2025, -$26.8 million in Q3 2025, and -$13.8 million in Q2 2025.